Skip to main content
. 2021 Jul 31;26(15):4658. doi: 10.3390/molecules26154658

Figure 7.

Figure 7

Combinational DFMT treatment of Raji cells with CD38-targeting Fab’DARA DFMT coupled with CD20-targeting Fab’RTX DFMT. The combined treatment was compared to individual therapies at the same MORF1 equivalence. Percent apoptotic cells were determined after DFMT treatment and analyzed with Annexin V/Propidium Iodide staining via flow cytometry. All experiments were performed in triplicate and statistically analyzed by One-Way ANOVA and Tukey test. *** p < 0.001, n.s. nonsignificant.